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In work designed to learn whether the worm Trickinella spiralis could serve 
as  a  transmitting  host  for  Semliki  Forest  virus,  as  Syverton,  McCoy,  and 
Kooman  (1)  had  shown  for  the  lymphocytic choriomeningitis virus,  an  un- 
anticipated finding came  to light. A  material was found to  be present in  the 
livers of mice,  which had  survived an ordinarily fatal dose of Semliki Forest 
virus,  that  rendered normal mice resistant to  the virus.  The  finding was not 
related in any way to the presence or absence of T. spiralis in the experimental 
animals,  nor  did  it  bear  any  direct  relationship  to  the  use  of  helenine  (2), 
which had been employed in the experiments to save animals infected with the 
virus.  However,  since  the  initial  observation  was  made  in  trichinous  mice 
saved from an ordinarily fatal Semliki Forest virus infection by the adminis- 
tration of helenine, the various accompanying conditions had to be maintained 
in the early experiments until it could be shown  that  their inclusion was not 
essential to the repetition of the findings. 
Materials and Methods 
Virus.--The  Semlild  Forest  virus  used in  these  experiments  was  initially  isolated  by 
Smithburn and Haddow (3). It was obtained from Dr. W. F. Friedewald of Atlanta, Georgia. 
It is lethally pathogenic in high titre when administered intracerebrally, subcutaneously,  or 
intraperituneally to white mice. 
Pools of brains from about ten infected mice, harvested when some were dead and the 
remainder were showing characteristic signs of infection,  were prepared in 5 or 10 per cent 
suspension in either buffered saline (pH 7.0) or beef heart infusion broth (pH 7.4) and divided 
among a number of screw-capped vials for storage frozen under CO2 until ready for use. Kept 
in this way, the virus retained an adequate potency and a single batch was sufficient for 3 to 
4 months of experimental work. In the present experiments, infections were induced by the 
subcutaneous  inoculation,  under the loose skin of the back, of 0.5 cc. of a dilution calculated 
to contain at least 100 ~s.L.D.'S  of virus. 
Tridtina.--A strain of T. spiralis obtained at The Rockefeller Institute from Dr. Helen 
Wells was used. This was maintained in white mice and infestations in other mice were in- 
duced by feeding either crude muscle preparations containing larvae or suspensions of larvae 
obtained by pepsin-hydrochloric acid digestion of infested muscle. 
511 512  IMMUNIZING SUBSTANCE ]~OR  SEMLIKI FOREST VIRUS 
Hdenine.--This  was prepared from  the pellicles of Penicillium funiculosum (4) and was 
administered intraperitoneally as previously described  (2). 
EXPERIMENTAL 
The Initial  ObservaHon.--Muscle, brain,  liver,  and spleen were harvested by an 
aseptic  technique from a group of trichinous  mice which 15 days earlier  had been 
infected subcutaneously with an ordinarily  fatal  dose of Semliki  Forest virus and 
then saved by prompt treatment with helenine.  The harvested tissues  were pooled 
and stored overnight in the freezing compartment of a refrigerator before suspending 
them to  10 per cent by grinding in a  mortar with saline containing 1,000  units of 
penicillin G and 10 rag. streptomycin per cc. Each of fifteen white mice was inoculated 
intraperitoneally with 0.5 cc. of the suspension in order to learn whether any infective 
virus persisted in either the trichinae present in the muscles or free in the liver, spleen, 
or brain of the recovered mice. When, 8 days later, all fifteen mice remained healthy, 
they were given a  second intraperitoneal injection of  the  same suspension,  stored 
frozen in the interval in the  CO2 box in screw-capped vials. All animals remained 
normal after the second injection. 2 weeks later they, together with 8 control mice of 
about the same age, were inoculated subcutaneously with approximately 100 M.L.D'S 
of Semliki Forest virus. All eight control mice died, but seven of the fifteen mice that 
had received the suspension of tissues from the recovered animals survived and later 
withstood challenge with a large dose of virus. 
The result obtained in this first experiment suggested that something within 
the tissues of immune mice was capable of conferring upon other mice an active 
type of immunity against Semliki Forest virus. Whether T. spiralis or helenine 
treatment played any actual role in the phenomenon  could not be told from 
the experiment. Also it was not apparent whether  the immunizing substance 
had been present in all of the tissues contained in the mixture tested or whether 
the activity resided in one particular tissue. 
In order to answer some of the questions raised by the preliminary observa- 
tion, a  second experiment was conducted. 
Groups of normal and trichinous  mice were infected with Semliki Forest virus and  then 
treated with helenine.  Four trichinous and  six non-trichinous  mice of those treated with 
helenine survived and these were sacrificed on the 12th day to furnish tissues for the experi- 
ment.  Muscle, brain, liver, and spleen were harvested separately from  the animals of each 
group and pooled by groups. They were frozen overnight in the freezing compartment of a 
refrigerator  and then suspended by grinding in mortars in saline containing the same amounts 
of penicillin and streptomycin as had been employed in the first experiment. The spleens were 
made to 5 per cent suspensions by wet weight and the muscle, brain, and liver suspensions 
were all 10 per cent. The tissue suspensions derived from the recovered trichinous mice were 
labeled "trichina" brain,  mucle, spleen, or liver, and those  from the recovered  non-trichi- 
nous mice "normal" brain, muscle, spleen, or liver. The suspensions were stored frozen under 
COs in screw-capped vials for a number of days prior to use and then were administered 
intraperitoneally  in 0.5 cc. doses to mice. The intraperitoneal injections were repeated 8 days 
later and challenge with Semliki Forest virus was made subcutaneously  14 days after the 
second injection of tissue suspension. The control mice were of the same age as the others in 
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As  can be  seen from Table I,  suspensions  of muscle,  brain  or  spleen from 
neither  the  "trichinous"  nor  the  "normal"  mice  conferred  any  protection 
against  Semliki Forest virus upon the mice to which they were administered. 
Suspensions  of livers, on the other hand,  whether  from trichinous  or normal 
mice, conferred a  degree of immunity adequate to protect most of the animals 
against a  stiff challenge dose of virus. 
This  experiment answered  two  of  the  questions  left unsettled  in  the  first 
experiment by making plain that  trichina played no  role in  the phenomenon 
and that the immunizing substance, whatever its nature might be, was present 
in  detectable  amounts  only in  the  liver.  It  left  unanswered  the  question  of 
TABLE  I 
Failure of Trichina Infestation to Influence Immunity Con/erred by the Livers of 
Mice Recovered from Semliki Forest Virus 
Preliminary treatment--lnjected  intraperitoneally  twice 
at  8-day  intervals  with 
"Normal" brain .......................................... 
"Trichina"  "  .......................................... 
"Normal" spleen ......................................... 
"Trichina"  "  ......................................... 
"Normal" liver  .......................................... 
"Trichina"  "  .......................................... 
"Normal" muscle ........................................ 
"Trichina"  "  ........................................ 
Controls--no treatment ................................... 
Result of test for immunity 
to Semliki Forest virus 
Survivors 
*0/7 
0/7 
O/8 
O/8 
7/8 
6/8 
1/7 
O/7 
2/iS 
•  Mice surviving 
No. of mice in group" 
whether treatment with helenine of the mice supplying the tissues had played 
a role. This question was answered in the next experiment to be outlined. 
For this experiment, mice surviving as shown in Table I were used  as a source of tissues. 
Livers and brains were harvested  14 days after infection from the two surviving control  mice 
and the one mouse in the "normal" muscle group that survived, and were prepared in 10 per 
cent suspension as previously  described. These suspensions were designated  as  "recovered" 
brain  or liver. In like manner,  livers and brains were also harvested  from the thirteen  mice 
surviving  in  the  "trichina" and  "normal" liver groups  and  were prepared  in  10 per cent 
suspension, as described. These suspensions were designated  "immune" brain and liver. The 
distinction between "recovered" and "immune" in this classification was an arbitrary one and 
served only to distinguish the tissues derived from groups of mice in which most of the ani- 
mals survived, apparently  as a result of resistance that had been conferred by previous treat- 
ment, from those of groups in which only an occasional mouse survived the challenge dose of 
virus. As in the preceding experiment, groups of normal mice were given two intraperitoneal 
injections at 8-day intervals of suspensions of either "immune" or "recovered" brain or liver. 
They were challenged 2 weeks after the second injection  by infection subcutaneously  with 
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The results obtained in the experiment just outlined are given in Table II. 
They show that the livers but not the brains of mice surviving infection with 
Semliki Forest virus, either naturally or as a result of previous treatment with 
livers of recovered mice, also contain the immunizing material. In this experi- 
ment, helenine-cured mice were not used as a  source of the immunizing liver 
suspensions,  and hence  helenine,  like trichinae,  can be eliminated  from con- 
sideration as playing any role in the phenomenon under discussion. 
TABLE  II 
Resistance to Semliki Forest Virus Conferred by Liver Suspensions from Recovered 
and Immune Mice 
Preliminary treatment--lnjected intraperitoueslly twice 
at 8-day intervals with 
"Recovered" brain ....................................... 
"Immune"  "  ....................................... 
"Recovered" ]iver  ........................................ 
"Immune"  "  ........................................ 
Controls--no treatment ................................... 
Result of test for immunity 
to Semllki Forest virus 
Survivors 
*O/8 
0/8 
8/8 
6/8 
0/7 
Mice surviving 
No. of mice in group 
DISCUSSION 
The results  outlined indicate that a material capable of rendering mice re- 
sistant to Semliki Forest virus was present in the livers but not in the muscles, 
brains,  or  spleens  of mice  that  had  survived  a  usually  fatal  dose  of virus. 
Although the initial observation was made using tissues from trichinous  mice 
that had been  "cured"  of their virus infections by treatment with  helenine, 
subsequent work has proved that neither the trichinae nor helenine play any 
role in the phenomenon.  It would appear rather that the material present in 
the livers is peculiar to the hepatic tissue of mice rendered immune by exposure 
to an ordinarily fatal dose of virus. That it is not Semliki Forest virus in trace 
amounts has been shown in subsequent experiments by the failure of effective 
liver  suspensions  to  produce  infection  when  administered  intracerebrally  to 
young mice. 
It seems likely, in view of its effectiveness in rendering mice resistant to ap- 
parent infection with Semliki Forest virus, that the material must in some way 
be closely related to that virus--perhaps the protein component of the agent, 
segregated and stored in the liver separate from infective nucleic acid, with its 
viral antigenicity fully intact.  The possibility  that  it may be  interferon  or 
a  similar substance or  stored  concentrated  viral  antibody  cannot  be  ruled RICHARD  E.  SHOVE  515 
out  from  the  present  experiments.  Further  work  to  be  reported  later  has 
been designed to throw light upon the character of the material, to determine 
its relationship to infective Semliki Forest virus,  and to indicate the role it 
may play in engendering a continuing immunity in the recovered animal. 
SUM-tag.RY 
A  material capable  of rendering mice resistant  to  Semliki  Forest  virus  is 
present in the livers but not in the muscles, brains, or spleens of mice that have 
survived a usually fatal dose of virus. 
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